Why Editas Medicine Stock Is Tumbling Today

Why Editas Medicine Stock Is Tumbling Today

Source: 
Motley Fool
snippet: 

Shares of Editas Medicine (NASDAQ:EDIT) were tumbling 16.3% as of 11:28 a.m. EST on Monday. The biotech made several announcements prior to its presentation at the annual J.P. Morgan Healthcare Conference on Wednesday. The update that likely most rattled investors was that Editas' chief scientific officer, Charles Albright, is leaving the company to pursue another opportunity.